Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
ORCX: The 2X Oracle ETF's -31% Drop Over 30 Days and -45% Over the Quarter

ORCX: The 2X Oracle ETF's -31% Drop Over 30 Days and -45% Over the Quarter

Key Takeaways

  • The Defiance Daily Target 2X Long ORCL ETF (ORCX) fell roughly 31% over the last 30 days, extending a steeper decline of approximately 45% over the trailing three months.
  • ORCX is a single-stock leveraged ETF that seeks two times (200%) the daily percentage change in Oracle Corporation (ORCL), before fees and expenses.
  • The decline reflects Oracle's aggressive, debt-funded artificial intelligence (AI) infrastructure buildout, a $20 billion equity-and-debt raise, negative free cash flow, and investor concern over funding and dilution.
  • Macroeconomic pressure, including a hotter-than-expected inflation print, amplified Oracle's interest-rate sensitivity and weighed on the broader AI infrastructure complex.
  • Because ORCX resets leverage daily, compounding and volatility decay can cause long-term returns to diverge meaningfully from two times Oracle's cumulative move.
  • For additional detail on this fund's outlook, explore Price Targets and the Forecast pages.
  • Discover automated, signal-driven strategies on the Trending AI Robots page.

ORCX Overview and Portfolio Exposure

ORCX is an actively managed, non-diversified exchange-traded fund (ETF) that attempts to deliver two times (200%) the daily percentage change in the share price of Oracle Corporation (ORCL). It achieves this exposure through derivatives, principally swap agreements and listed options, rather than by directly holding Oracle stock. The fund's largest reported position is a cash-collateral holding in the First American Government Obligations Fund, while its effective market exposure is concentrated almost entirely in Oracle, placing the portfolio within the information technology sector.

The fund carries a net expense ratio of approximately 1.29% and manages roughly $230 million in assets under management (AUM). It launched in February 2025. This concentrated, daily-reset structure means ORCX does not simply double Oracle's longer-term performance: it doubles each day's move and then resets, so multi-day compounding, volatility, and the fund's own fees all influence the path of returns. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the sector.

ORCX Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ORCX declined roughly 31%, moving from a closing level near $17.78 to approximately $12.27. The decline was not linear: the fund posted several sharp single-day swings in both directions, consistent with the high volatility of its leveraged, single-stock exposure. Over the trailing three months, the drawdown has been larger, with the fund falling approximately 45% from levels near $22 in early August.

This performance pattern is best described as a volatile, trend-driven decline rather than a gradual, range-bound slide. The fund's leverage amplified Oracle's downside moves on risk-off sessions while also producing outsized intraday reversals, including a brief rally around Oracle's late-October investor day that was subsequently given back.

What Drove ORCX Price in the Last 30 Days

The dominant driver of ORCX's recent ETF performance was the sharp repricing of Oracle shares, which the fund magnifies roughly two-to-one on a daily basis. Several identifiable catalysts weighed on Oracle during the period. The company completed a $20 billion capital raise split between new equity and senior notes, with the share component priced at a notable discount, raising concerns about shareholder dilution and debt-funded expansion. Capital expenditures surged to roughly $28.5 billion in Oracle's latest fiscal quarter, pushing free cash flow (FCF) into negative territory despite strong cloud infrastructure revenue growth.

Macroeconomic conditions compounded the pressure. A hotter-than-expected consumer inflation print reinforced expectations that borrowing costs could stay elevated, increasing the financing burden of Oracle's capital-intensive buildout and triggering a sharp single-session decline. A broader selloff across AI infrastructure names, partly triggered by large-cap technology earnings, added to the rotation away from capital-intensive AI growth stories. Reports of a scaled-back overseas semiconductor rental arrangement further pressured sentiment. Because ORCX holds two times daily leverage, each of these Oracle moves was amplified in the fund's net asset value (NAV) and market price. From what I see, this leverage dynamic is important because it magnifies both gains and losses in ways that can surprise longer-term holders.

What Drove ORCX Performance Over the Last Quarter

The three-month decline reflects a longer-running reassessment of Oracle's financing model rather than isolated news. Over 2026, Oracle has pivoted aggressively toward AI cloud infrastructure, funded by rising net debt and recurring equity issuance, while free cash flow has turned negative. This profile made the stock especially sensitive to interest-rate expectations and to a broader market rotation that favored cash-generative technology businesses over high-capex AI buildouts.

Institutional positioning and sector rotation amplified the move. As investors differentiated among AI beneficiaries, Oracle's heavy balance-sheet leverage and dilutive funding drew scrutiny even as its remaining performance obligations (RPO) climbed to record levels. For ORCX, this underlying drawdown was compounded by the daily reset mechanics and volatility decay inherent to leveraged ETFs, causing the fund's cumulative loss to exceed two times Oracle's own decline over the same period. I'm watching this closely as the volatility decay effect stands out in leveraged products like this one.

ORCX ETF Outlook: What Investors Should Watch Next

The primary factors likely to influence ORCX in the months ahead center on Oracle's ability to convert contracted AI demand into recognized revenue while restoring positive free cash flow. Investors should monitor Oracle's upcoming quarterly results, capital expenditure guidance, and any further equity or debt issuance, since dilution and financing costs have been central to the stock's repricing. Interest-rate expectations and inflation data will remain important, given the fund's sensitivity to borrowing costs and the leveraged structure of Oracle's expansion.

Broader AI infrastructure sentiment, data-center execution milestones, and regulatory developments around large-scale projects also represent potential catalysts in either direction. Separately, holders of ORCX should account for the structural effects of daily leverage resetting, which can erode value in volatile, range-bound markets even when the underlying stock's net move is modest. The outlook is therefore balanced between Oracle's strong contracted backlog and the execution, funding, and volatility risks that have defined the fund's recent performance.

Using Tickeron’s AI Screener for Research

In my own analysis, I turned to Tickeron’s AI Screener to quickly scan for comparable leveraged ETFs and single-stock products, applying filters for volatility, sector exposure, and recent performance. It surfaces ideas based on technical indicators, fundamentals, and AI signals without requiring hours of manual review, which helps refine watchlists when markets shift quickly like they have around AI infrastructure names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for ORCX turns negative, indicating new downward trend

ORCX saw its Momentum Indicator move below the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator turned negative. In 20 of the 22 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ORCX turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In 13 of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ORCX entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +29.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCX advanced for three days, in 83 of 89 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

ORCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Oracle Corporation (NYSE: ORCL). The fund is an actively managed exchange traded fund (“ETF”) that attempts to achieve two times (200%) the daily percentage change in the share price of the underlying security by employing derivatives, namely swap agreements and/or listed options contracts. The fund is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
United States
Phone
N/A
Web
N/A
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.